Intranasal Epinephrine/Guidelines/Higher Learning
Introduced
Moved
Reached a final decision
Became law
Derived from the official record below.
Officially: “AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE APPLICATION OF NASAL EPINEPHRINE.” Read the full text
153rd General Assembly
What it does
This Act adds authority and guidelines for access to and use of intranasal epinephrine nasal sprays at institutions of higher education to the existing framework for access to and use of epinephrine injectors. This Act also removes the requirement of the Department of Public Health from filing an annual report regarding the use of epinephrine autoinjectors for the prior academic year with the General Assembly under this section.
From the official legislative record, shown verbatim. Not legal advice.
Where it is
Introduced · Jun 4, 2026
Signed · Jul 28, 2026
Latest official status shown, exactly as the official record states it. The step by step history lives on the official page linked below.
The numbers
1
sponsor on the bill
Sponsors
Recorded votes
Recorded voteSenate · 2026-06-30 · Passed · Yes 21, No 0, NotVoting 0, Conflict 0, Absent 0, Vacant 0
Recorded voteHouse · 2026-06-11 · Passed · Yes 38, No 1, NotVoting 0, Conflict 0, Absent 2, Vacant 0
Roll-call results shown verbatim from the Delaware legislature’s records. A result reflects that roll call’s own motion, not the bill’s overall outcome.
Every fact on this page links to its source, starting with the official bill record. Last action: Signed (Jul 28, 2026).